Study Probes Connection Between Excessive Screen Media Activity and Mental Health Problems in Youth
Smartphones, tablets, gaming systems, and other screen devices have become a major temptation for people of all ages, but a new study is focusing on the possible connection between excessive screen media activity and mental health problems in youth.
Participatory Action Research Study Demonstrates the Value of Team Science Led by People in Mental Health Recovery
A new study led by members of Fountain House, the originator of the “Clubhouse” model of mental health, in partnership with researchers in the Yale Department of Psychiatry demonstrates the power of studies led by people in mental health recovery.
Study: People Who Regularly Drink Alcohol Could Be More Prone to Internet, Gaming, and Exercise Addiction
An international research team with members that include Yale scientist Marc Potenza, MD, PhD, have identified several genes and their variants that trigger both substance use and other potentially addictive behaviors.
Epidemiologic and Genetic Associations of Endometriosis With Depression, Anxiety, and Eating Disorders
A Yale-led study published in JAMA Network Open is the first large-scale analysis to investigate phenotypic and genetic factors contributing to the psychiatric comorbidity of endometriosis, a complex gynecologic disease.
Confronting Racially Exclusionary Practices in the Acquisition and Analyses of Neuroimaging Data
A new paper by Yale School of Medicine researchers challenges scientists in the global neuroscience community to create a more diverse representation of study participants through improved recruitment and enhanced methodological and analysis practices.
Krystal Research Published in The Lancet
Data from an early phase clinical trial of a drug being developed for adults living with schizophrenia was published December 15 in The Lancet. John H. Krystal, MD, Robert L. McNeil, Jr. Professor of Translational Research and professor of psychiatry, of neuroscience, and of psychology, and chair of the Yale Department of Psychiatry, is first author of the study of the drug emraclidine, developed by Cerevel Therapeutics.
Yale Department of Internal Medicine Celebrates Top Female Scientists
Last month, Research.com published the Best Female Scientists in 2022. The results were based on a ranking system which measures the impact of a researcher’s publications by combining the number of papers they have published and how often they are cited by other papers. 623 U.S.-based researchers appeared in list with three women representing the Yale Department of Internal Medicine.
Collaboration on NIH grant between Sullivan, Nez Henderson will create program to help Indigenous women experiencing domestic violence quit smoking
Tami Sullivan, PhD, associate professor of psychiatry at Yale School of Medicine, and Patricia Nez Henderson, MD, MPH, vice president for the Black Hills Center for American Indian Health (BHCAIH) and the first Indigenous woman to graduate from Yale School of Medicine, have been awarded a grant from the National Institutes of Health (NIH) to pilot a mindfulness-based, culturally-tailored smoking cessation intervention for Indigenous women who experience intimate partner violence (IPV).
Yale Study Revises Understanding of How the Brain Processes and Responds to Rewards
A new Yale study of neuron activity in the brain has revised scientists’ understanding of how the brain processes and responds to rewards. Marina Picciotto, PhD, Charles B. G. Murphy Professor of Psychiatry and Professor in the Child Study Center, of Neuroscience and of Pharmacology, is the study’s senior author.
De Aquino Awarded IMPOWR-YOU Grant to Study Pain Sensitivity, Opioid Use Disorder
Joao P. De Aquino, MD, assistant professor of psychiatry, has been awarded a pilot grant from the Integrative Management of Chronic Pain and Opioid Use Disorder for Whole Recovery-Yale and Organizations United (IMPOWR-YOU) Research Center to evaluate the relationship between pain sensitivity and brain synaptic density among people with opioid use disorder (OUD).
Yale Scientists Identify Genetic Risk Factors for Opioid Use and Related Substance Use Disorders
A new human genomics study led by Yale scientists has identified genetic risk factors for opioid use disorder (OUD) and related substance use disorders according to a new large-scale genome-wide association study – increasing the number of risk genes known from 1 to 19.